Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05425992 · ClinicalTrials.gov registry record
Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families
A clinical trial of Leukemia and Non-Hodgkin Lymphoma, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05425992 is a study of Leukemia and Non-Hodgkin Lymphoma that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 20 participants, below the 487-participant average among 233 other Leukemia trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05425992, a study of Leukemia and Non-Hodgkin Lymphoma, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will seek to improve communication with Spanish speaking families and patients with Cancer and Blood Disorders.
Conditions Studied
Interventions
- OTHER Interview
Study Locations (1)
Colorado
- Children's Hospital Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-03-17 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05425992
The ClinicalTrials.gov registry entry for NCT05425992 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 487-participant average among 233 other Leukemia trials with a reported enrollment target (96% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Leukemia appearing as the primary indexed condition, and to 1 intervention - of which Interview is the first listed.
NCT05425992 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT05425992 about?
NCT05425992 is a clinical study titled "Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families". This study will seek to improve communication with Spanish speaking families and patients with Cancer and Blood Disorders.
What is the current status of trial NCT05425992?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2022-03-17. Estimated completion is 2027-12-31.
What conditions does trial NCT05425992 study?
This clinical trial studies the following conditions: Leukemia, Non-Hodgkin Lymphoma.
What interventions are being tested in trial NCT05425992?
The interventions under investigation include: Interview (OTHER).
Who is sponsoring clinical trial NCT05425992?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05425992 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
RECRUITING · Early Phase 1
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
-
Revumenib in Combination With 7+3 + Midostaurin in AML
RECRUITING · Phase 1
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
RECRUITING · Phase 2
-
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.